DUBLIN, Dec. 28,
2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS)
announced today that its Chief Executive Officer, Richard Pops, will provide a corporate overview
and update at the 41st Annual J.P. Morgan Healthcare
Conference. The presentation will take place on Wednesday, Jan. 11, 2023 at 11:15 a.m. PST (2:15 p.m.
EST/7:15 p.m. GMT), followed
by a question and answer session. The live webcast may be accessed
under the Investors tab on www.alkermes.com and will be
archived for 14 days.
About Alkermes plc
Alkermes plc is a fully-integrated, global
biopharmaceutical company developing innovative medicines in the
fields of neuroscience and oncology. The company has a portfolio of
proprietary commercial products focused on alcohol dependence,
opioid dependence, schizophrenia and bipolar I disorder, and a
pipeline of product candidates in development for neurological
disorders and cancer. Headquartered in Dublin,
Ireland, Alkermes has a research and development center
in Waltham, Massachusetts; a research and manufacturing
facility in Athlone, Ireland; and a manufacturing facility
in Wilmington, Ohio. For more information, please visit
Alkermes' website at www.alkermes.com.
Contact:
Jamie Bernard
Investor Relations
+1 781 873-2402
View original content to download
multimedia:https://www.prnewswire.com/news-releases/alkermes-to-present-at-the-41st-annual-jp-morgan-healthcare-conference-301710669.html
SOURCE Alkermes plc